Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fuster

Showing results (211-220 of 512) with videos related to

Pageof 52
Sort By:
Annals of Human Biology|February 8, 2013
Factors determining the variation in birth weight in Spain (1980-2010)V Fuster, P Zuluaga, S E Colantonio, et al.
Journal of Biomaterials Applications|July 1, 1990
Platelet interaction to prosthetic materials--role of von Willebrand factor in platelet interaction to PTFEL Badimon, J J Badimon, V T Turitto, et al.
Current Problems in Cardiology|July 1, 1988
Antithrombotic therapy for patients with cardiac diseaseW J Penny, J H Chesebro, M Heras, et al.
Bailliere'S Clinical Haematology|July 1, 1990
Antithrombotic therapy for coronary artery disease and valvular heart diseaseD H Israel, V Fuster, J H Chesebro, et al.
ASAIO Transactions|July 1, 1987
Role of von Willebrand factor in platelet interaction with an expanded PTFE surfaceL Badimon, J J Badimon, V T Turitto, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 28, 1999
Antithrombotic effect of FK506 vs cyclosporine in cardiac transplant recipients: potential implications in transplant arteriopathyR Freudenberger, J Alexis, A Gass, et al.
Circulation|September 1, 1986
Intraoperative echocardiography for the evaluation of valvular regurgitation: experience in 263 patientsM E Goldman, V Fuster, T Guarino, et al.
British Medical Journal|August 7, 1971
Effects of poisoning on serum enzyme activities, coagulation, and fibrinolysisN Wright, A R Clarkson, S S Brown, et al.
Circulation|February 1, 1993
Aspirin as a therapeutic agent in cardiovascular disease. Special Writing GroupV Fuster, M L Dyken, P S Vokonas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 14, 2001
Mechanism of action and pharmacology of unfractionated heparinJ Hirsh, S S Anand, J L Halperin, et al.
Pageof 52

Showing results (211-220 of 512) with videos related to

Sort By:
Pageof 52
Annals of Human Biology|February 8, 2013
Factors determining the variation in birth weight in Spain (1980-2010)V Fuster, P Zuluaga, S E Colantonio, et al.
Journal of Biomaterials Applications|July 1, 1990
Platelet interaction to prosthetic materials--role of von Willebrand factor in platelet interaction to PTFEL Badimon, J J Badimon, V T Turitto, et al.
Current Problems in Cardiology|July 1, 1988
Antithrombotic therapy for patients with cardiac diseaseW J Penny, J H Chesebro, M Heras, et al.
Bailliere'S Clinical Haematology|July 1, 1990
Antithrombotic therapy for coronary artery disease and valvular heart diseaseD H Israel, V Fuster, J H Chesebro, et al.
ASAIO Transactions|July 1, 1987
Role of von Willebrand factor in platelet interaction with an expanded PTFE surfaceL Badimon, J J Badimon, V T Turitto, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 28, 1999
Antithrombotic effect of FK506 vs cyclosporine in cardiac transplant recipients: potential implications in transplant arteriopathyR Freudenberger, J Alexis, A Gass, et al.
Circulation|September 1, 1986
Intraoperative echocardiography for the evaluation of valvular regurgitation: experience in 263 patientsM E Goldman, V Fuster, T Guarino, et al.
British Medical Journal|August 7, 1971
Effects of poisoning on serum enzyme activities, coagulation, and fibrinolysisN Wright, A R Clarkson, S S Brown, et al.
Circulation|February 1, 1993
Aspirin as a therapeutic agent in cardiovascular disease. Special Writing GroupV Fuster, M L Dyken, P S Vokonas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 14, 2001
Mechanism of action and pharmacology of unfractionated heparinJ Hirsh, S S Anand, J L Halperin, et al.
Pageof 52